Deaths due to vascular events · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death by any cause · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in death by any cause compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Dementia · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in dementia compared with placebo or no treatment (high certainty).
1 finding from 1 review
Motor function
1 finding from 1 review
Motor impairment at the end of intervention phase: all outcome measures
1 finding from 1 review
Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity.
1 finding from 1 review
Activities of daily living
1 finding from 1 review
Pain at the end of intervention phase: all studies
1 finding from 1 review
Pain at the end of intervention phase after excluding studies with CRPS
1 finding from 1 review
Visuospatial neglect at the end of intervention: all studies
1 finding from 1 review
Intervention not reported
Case fatality at the end of · patients with acute ischaemic or haemorrhagic stroke
The intervention showed no clear difference in case fatality at the end of (high certainty).
1 finding from 1 review
Intervention not reported
Poor functional outcome at the end of · patients with acute ischaemic or haemorrhagic stroke
The intervention showed no clear difference in poor functional outcome at the end of (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of infections at the end of · patients with acute ischaemic or haemorrhagic stroke
The intervention leads to lower number of infections at the end of (high certainty).
1 finding from 1 review
Intervention not reported
Number of UTIs at the end of · patients with acute ischaemic or haemorrhagic stroke
The intervention leads to lower number of UTIs at the end of (high certainty).
1 finding from 1 review
Intervention not reported
Number of pneumonias at the end of · patients with acute ischaemic or haemorrhagic stroke
The intervention showed no clear difference in number of pneumonias at the end of (high certainty).
1 finding from 1 review
Intervention not reported
Occurrence of elevated body temperature · patients with acute ischaemic or haemorrhagic stroke
1 finding from 1 review
Intervention not reported
Rate of serious adverse events · patients with acute ischaemic or haemorrhagic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Stroke and other systemic embolic events · people with atrial fibrillation deemed eligible for long‐term anticoagulant treatment
The intervention leads to lower stroke and other systemic embolic events (high certainty).
1 finding from 1 review
Intervention not reported
All strokes · people with atrial fibrillation deemed eligible for long‐term anticoagulant treatment
The intervention leads to lower all strokes (high certainty).
1 finding from 1 review
Intervention not reported
Major bleedings · people with atrial fibrillation deemed eligible for long‐term anticoagulant treatment
The intervention probably leads to lower major bleedings (moderate certainty).
1 finding from 1 review